Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cyst Fibros ; 22(2): 266-274, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36319569

RESUMEN

BACKGROUND AND AIMS: People with cystic fibrosis (PwCF) suffer from gastrointestinal (GI) symptoms affecting their quality of life (QOL). Despite the relevance of GI symptoms to the overall health of PwCF, a paucity of studies only have comprehensively assessed the prevalence, severity and QOL of GI symptoms in both children and adults with Cystic Fibrosis (CF). METHODS: Eligible participants ≥2 years of age across 26 US CF centers were followed for 4 weeks. Three validated GI electronic patient-reported outcome measures (ePROMs) with a recall period of 2 weeks and a stool-specific questionnaire were administered weekly over four weeks. Total and domain scores of ePROMs were evaluated overall and in subgroups using linear mixed-effect models. RESULTS: Of 402 enrolled, 58% were ≥ 18 years of age (52% male). The mean (SD) of the total score for PAC-SYM was 0.52 (0.55), for PAGI-SYM was 0.63 (0.67), and for PAC-QOL was 0.67 (0.55). For specific ePROM questions, prevalence of moderate to very severe symptoms were as follows: straining (20.3%), fullness (18.3%), incomplete bowel movements (17.1%), bloating (16.4%), distension (16.4%), abdominal pain (upper-5.1%, lower-7.5%). Comparing participants ≥18 versus <18, a higher prevalence of bloating (63.7% versus 27.3%), lower abdominal pain (39.8% vs 26.2%), stomach fullness (75.6% versus 56.2%), and abdominal distension (60.2% versus 34.9%) was found. Both age groups reported high treatment dissatisfaction as measured with PAC-QOL, mean 1.39 (95% CI: 1.30, 1.47). CONCLUSION: GI symptoms were reported in all age ranges irrespective of gender, with higher prevalence observed amongst older and female subgroups. Dissatisfaction with GI targeted treatments were reported in a large proportion of participants despite therapy, highlighting an unmet need for clinical interventions. CLINICALTRIALS: GOV: NCT03801993.


Asunto(s)
Fibrosis Quística , Enfermedades Gastrointestinales , Adulto , Niño , Humanos , Masculino , Femenino , Lactante , Fibrosis Quística/complicaciones , Fibrosis Quística/diagnóstico , Fibrosis Quística/epidemiología , Calidad de Vida , Estudios Prospectivos , Enfermedades Gastrointestinales/diagnóstico , Enfermedades Gastrointestinales/epidemiología , Enfermedades Gastrointestinales/etiología , Dolor Abdominal/diagnóstico , Dolor Abdominal/epidemiología , Dolor Abdominal/etiología
2.
J Cyst Fibros ; 20(4): 598-604, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33451899

RESUMEN

BACKGROUND: Gastrointestinal (GI) involvement among persons with cystic fibrosis (CF) is highly prevalent, representing a significant source of morbidity. Persons with CF have identified GI concerns as a top research priority, yet universal clinical outcome measures capturing many of the GI symptoms experienced in CF are lacking. The GALAXY study was envisioned to address this unmet need. METHODS: The GALAXY study team partnered with Community Voice, a community of patients with CF and their caregivers, to identify the patient reported outcome measures that most accurately reflected their experience with GI symptoms in CF. We also surveyed CF care teams to identify the comfort level of various team members (providers, nurses and dieticians) in managing a variety of GI conditions. RESULTS: Members of Community Voice identified the combination of PAC-SYM, PAGI-SYM, PAC-QOL and the Bristol Stool scale with three additional symptom-specific questions as patient-reported outcome measures that comprehensively captured the CF experience with GI disease. CF care team providers reported a high level of comfort in treating GI conditions including constipation (92%), GERD (93%), and gassiness (77%), however comfort level was limited to only first-line interventions. CONCLUSION: By partnering with persons with CF as well as their caregivers and medical providers, the GALAXY study is designed to uniquely capture the prevalence and severity of GI involvement among persons with CF in a manner that reflects the CF patient experience. The results of GALAXY will inform the development of future interventional trials and serve as a reproducible and objective study endpoint.


Asunto(s)
Fibrosis Quística/diagnóstico , Enfermedades Gastrointestinales/diagnóstico , Fibrosis Quística/complicaciones , Enfermedades Gastrointestinales/etiología , Humanos , Estudios Longitudinales , Medición de Resultados Informados por el Paciente , Estudios Prospectivos , Evaluación de Síntomas
3.
J Gen Physiol ; 145(5): 431-42, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25918361

RESUMEN

Although PI(4,5)P2 is believed to play an essential role in regulating the activity of numerous ion channels and transporters, the mechanisms by which it does so are unknown. Here, we used the ability of the TRPV1 ion channel to discriminate between PI(4,5)P2 and PI(4)P to localize the region of TRPV1 sequence that interacts directly with the phosphoinositide. We identified a point mutation in the proximal C-terminal region after the TRP box, R721A, that inverted the selectivity of TRPV1. Although the R721A mutation produced only a 30% increase in the EC50 for activation by PI(4,5)P2, it decreased the EC50 for activation by PI(4)P by more than two orders of magnitude. We used chemically induced and voltage-activated phosphatases to determine that PI(4)P continued to support TRPV1 activity even after depletion of PI(4,5)P2 from the plasma membrane. Our data cannot be explained by a purely electrostatic mechanism for interaction between the phosphoinositide and the protein, similar to that of the MARCKS (myristoylated alanine-rich C kinase substrate) effector domain or the EGF receptor. Rather, conversion of a PI(4,5)P2-selective channel to a PI(4)P-selective channel indicates that a structured phosphoinositide-binding site mediates the regulation of TRPV1 activity and that the amino acid at position 721 likely interacts directly with the moiety at the 5' position of the phosphoinositide.


Asunto(s)
Activación del Canal Iónico , Fosfatidilinositol 4,5-Difosfato/metabolismo , Canales Catiónicos TRPV/metabolismo , Secuencia de Aminoácidos , Animales , Línea Celular Tumoral , Células HEK293 , Humanos , Datos de Secuencia Molecular , Unión Proteica , Ratas , Canales Catiónicos TRPV/química
4.
J Biol Chem ; 289(16): 10999-11006, 2014 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-24599956

RESUMEN

Membrane asymmetry is essential for generating second messengers that act in the cytosol and for trafficking of membrane proteins and membrane lipids, but the role of asymmetry in regulating membrane protein function remains unclear. Here we show that the signaling lipid phosphoinositide 4,5-bisphosphate (PI(4,5)P2) has opposite effects on the function of TRPV1 ion channels depending on which leaflet of the cell membrane it resides in. We observed potentiation of capsaicin-activated TRPV1 currents by PI(4,5)P2 in the intracellular leaflet of the plasma membrane but inhibition of capsaicin-activated currents when PI(4,5)P2 was in both leaflets of the membrane, although much higher concentrations of PI(4,5)P2 in the extracellular leaflet were required for inhibition compared with the concentrations of PI(4,5)P2 in the intracellular leaflet that produced activation. Patch clamp fluorometry using a synthetic PI(4,5)P2 whose fluorescence reports its concentration in the membrane indicates that PI(4,5)P2 must incorporate into the extracellular leaflet for its inhibitory effects to be observed. The asymmetry-dependent effect of PI(4,5)P2 may resolve the long standing controversy about whether PI(4,5)P2 is an activator or inhibitor of TRPV1. Our results also underscore the importance of membrane asymmetry and the need to consider its influence when studying membrane proteins reconstituted into synthetic bilayers.


Asunto(s)
Membrana Celular/metabolismo , Fosfatidilinositol 4,5-Difosfato/metabolismo , Canales Catiónicos TRPV/metabolismo , Antipruriginosos/farmacología , Capsaicina/farmacología , Línea Celular , Membrana Celular/genética , Humanos , Fosfatidilinositol 4,5-Difosfato/genética , Canales Catiónicos TRPV/genética
5.
J Neurosci ; 33(12): 5249-60, 2013 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-23516290

RESUMEN

The ability to detect hot temperatures is critical to maintaining body temperature and avoiding injury in diverse animals from insects to mammals. Zebrafish embryos, when given a choice, actively avoid hot temperatures and display an increase in locomotion similar to that seen when they are exposed to noxious compounds such as mustard oil. Phylogenetic analysis suggests that the single zebrafish ortholog of TRPV1/2 may have arisen from an evolutionary precursor of the mammalian TRPV1 and TRPV2. As opposed to TRPV2, mammalian TRPV1 is essential for environmentally relevant heat sensation. In the present study, we provide evidence that the zebrafish TRPV1 ion channel is also required for the sensation of heat. Contrary to development in mammals, zebrafish TRPV1(+) neurons arise during the first wave of somatosensory neuron development, suggesting a vital importance of thermal sensation in early larval survival. In vitro analysis showed that zebrafish TRPV1 acts as a molecular sensor of environmental heat (≥25°C) that is distinctly lower than the sensitivity of the mammalian form (≥42°C) but consistent with thresholds measured in behavioral assays. Using in vivo calcium imaging with the genetically encoded calcium sensor GCaMP3, we show that TRPV1-expressing trigeminal neurons are activated by heat at behaviorally relevant temperatures. Using knock-down studies, we also show that TRPV1 is required for normal heat-induced locomotion. Our results demonstrate for the first time an ancient role for TRPV1 in the direct sensation of environmental heat and show that heat sensation is adapted to reflect species-dependent requirements in response to environmental stimuli.


Asunto(s)
Calor , Locomoción/fisiología , Células Receptoras Sensoriales/fisiología , Canales Catiónicos TRPV/fisiología , Proteínas de Pez Cebra/fisiología , Pez Cebra/fisiología , Ácidos/farmacología , Secuencia de Aminoácidos , Animales , Conducta Animal/fisiología , Capsaicina/farmacología , Carcinógenos/farmacología , Células HEK293 , Humanos , Sistema de la Línea Lateral/citología , Sistema de la Línea Lateral/fisiología , Datos de Secuencia Molecular , Fármacos del Sistema Sensorial/farmacología , Canales Catiónicos TRPV/agonistas , Canales Catiónicos TRPV/genética , Acetato de Tetradecanoilforbol/farmacología , Nervio Trigémino/citología , Nervio Trigémino/fisiología , Pez Cebra/genética , Proteínas de Pez Cebra/genética
6.
J Neurosci Methods ; 199(1): 35-42, 2011 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-21536068

RESUMEN

This article describes a perfusion system for biophysical single cell experiments at the physiological temperature. Our system regulates temperature of test solutions using a small heat exchanger that includes several capillaries. Water circulating inside the heat exchanger warms or cools test solutions flowing inside the capillaries. Temperature-controlled solutions are delivered directly to a single cell(s) through a multibarreled manifold that switches solutions bathing a cell in less than 1s. This solution exchange is optimal for patch clamp, single-cell microamperometry, and microfluorometry experiments. Using this system, we demonstrate that exocytosis from pancreatic ß cells and activation of TRPV1 channels are temperature sensitive. We also discuss how to measure local temperature near a single cell under investigation.


Asunto(s)
Electrofisiología/instrumentación , Exocitosis/fisiología , Calefacción/instrumentación , Activación del Canal Iónico/fisiología , Islotes Pancreáticos/fisiología , Perfusión/instrumentación , Análisis de la Célula Individual/instrumentación , Soluciones/administración & dosificación , Canales Catiónicos TRPV/fisiología , Temperatura , Animales , Calcio/administración & dosificación , Calcio/farmacología , Capsaicina/farmacología , Diseño de Equipo , Exocitosis/efectos de los fármacos , Colorantes Fluorescentes/análisis , Glucosa/farmacología , Indoles/análisis , Activación del Canal Iónico/efectos de los fármacos , Islotes Pancreáticos/citología , Islotes Pancreáticos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Micromanipulación/instrumentación , Técnicas de Placa-Clamp/instrumentación , Serotonina/análisis , Análisis de la Célula Individual/métodos , Soluciones/farmacología , Canales Catiónicos TRPV/efectos de los fármacos
7.
J Biol Chem ; 286(11): 9688-98, 2011 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-21224382

RESUMEN

Although a large number of ion channels are now believed to be regulated by phosphoinositides, particularly phosphoinositide 4,5-bisphosphate (PIP2), the mechanisms involved in phosphoinositide regulation are unclear. For the TRP superfamily of ion channels, the role and mechanism of PIP2 modulation has been especially difficult to resolve. Outstanding questions include: is PIP2 the endogenous regulatory lipid; does PIP2 potentiate all TRPs or are some TRPs inhibited by PIP2; where does PIP2 interact with TRP channels; and is the mechanism of modulation conserved among disparate subfamilies? We first addressed whether the PIP2 sensor resides within the primary sequence of the channel itself, or, as recently proposed, within an accessory integral membrane protein called Pirt. Here we show that Pirt does not alter the phosphoinositide sensitivity of TRPV1 in HEK-293 cells, that there is no FRET between TRPV1 and Pirt, and that dissociated dorsal root ganglion neurons from Pirt knock-out mice have an apparent affinity for PIP2 indistinguishable from that of their wild-type littermates. We followed by focusing on the role of the C terminus of TRPV1 in sensing PIP2. Here, we show that the distal C-terminal region is not required for PIP2 regulation, as PIP2 activation remains intact in channels in which the distal C-terminal has been truncated. Furthermore, we used a novel in vitro binding assay to demonstrate that the proximal C-terminal region of TRPV1 is sufficient for PIP2 binding. Together, our data suggest that the proximal C-terminal region of TRPV1 can interact directly with PIP2 and may play a key role in PIP2 regulation of the channel.


Asunto(s)
Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Fosfatidilinositol 4,5-Difosfato/metabolismo , Raíces Nerviosas Espinales/metabolismo , Canales Catiónicos TRPV/metabolismo , Animales , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Células HEK293 , Humanos , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Ratones Noqueados , Proteínas del Tejido Nervioso/genética , Neuronas/citología , Fosfatidilinositol 4,5-Difosfato/genética , Unión Proteica , Estructura Terciaria de Proteína , Raíces Nerviosas Espinales/citología , Canales Catiónicos TRPV/genética
8.
J Biol Chem ; 283(38): 26208-16, 2008 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-18574245

RESUMEN

Once thought of as simply an oily barrier that maintains cellular integrity, lipids are now known to play an active role in a large variety of cellular processes. Phosphoinositides are of particular interest because of their remarkable ability to affect many signaling pathways. Ion channels and transporters are an important target of phosphoinositide signaling, but identification of the specific phosphoinositides involved has proven elusive. TRPV1 is a good example; although phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P(2)) can potently regulate its activation, we show that phosphatidylinositol (4)-phosphate (PI(4)P) and phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P(3)) can as well. To determine the identity of the endogenous phosphoinositide regulating TRPV1, we applied recombinant pleckstrin homology domains to inside-out excised patches. Although a PI(4,5)P(2)-specific pleckstrin homology domain inhibited TRPV1, a PI(3,4,5)P(3)-specific pleckstrin homology domain had no effect. Simultaneous confocal imaging and electrophysiological recording of whole cells expressing a rapamycin-inducible lipid phosphatase also demonstrates that depletion of PI(4,5)P(2) inhibits capsaicin-activated TRPV1 current; the PI(4)P generated by the phosphatases was not sufficient to support TRPV1 function. We conclude that PI(4,5)P(2), and not other phosphoinositides or other lipids, is the endogenous phosphoinositide regulating TRPV1 channels.


Asunto(s)
Lípidos/química , Fosfatidilinositol 4,5-Difosfato/fisiología , Fosfatidilinositoles/química , Canales Catiónicos TRPV/metabolismo , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Humanos , Ratones , Microscopía Confocal , Modelos Biológicos , Fosfatidilinositol 4,5-Difosfato/metabolismo , Polilisina/química , Unión Proteica , Transducción de Señal
9.
Clin Exp Pharmacol Physiol ; 35(9): 1121-6, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18215181

RESUMEN

Voltage-dependent, L-type Ca2+ channels (LTCC) play an essential role in arterial smooth muscle contraction and, consequently, the regulation of arterial diameter, tissue perfusion and blood pressure. However, the spatial organization of functional LTCC in arterial myocytes is incompletely understood. Total internal reflection fluorescence and swept-field confocal microscopy revealed that the opening of a single or a cluster of LTCC produces local elevations in [Ca2+]i called Ca2+ sparklets. In arterial myocytes, Ca2+ sparklets are produced by the opening of Cav1.2 channels. The Ca2+ sparklet activity is bimodal. In low activity mode, rare stochastic openings of solitary LTCC produce limited Ca2+ influx ('low activity Ca2+ sparklets'). In contrast, discrete clusters of LTCC associated with protein kinase Ca (PKCa) operate in a sustained, high-activity mode resulting in substantial Ca2+ influx ('persistent Ca2+ sparklets'). The Ca2+ sparklet activity varies regionally within a myocyte depending on the relative activities of nearby PKCa and opposing protein phosphates 2A and 2B. Low- and high-activity persistent Ca2+ sparklets modulate local and global [Ca2+]i in arterial smooth muscle, suggesting that this Ca2+ signal may play an important role in the regulation of vascular function.


Asunto(s)
Arterias/metabolismo , Canales de Calcio Tipo L/fisiología , Señalización del Calcio/fisiología , Músculo Liso Vascular/metabolismo , Animales , Calcio/metabolismo , Canales de Calcio Tipo L/metabolismo , Humanos , Modelos Biológicos , Miocitos del Músculo Liso/metabolismo
10.
J Gen Physiol ; 128(5): 509-22, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17074976

RESUMEN

Sensitization of the pain-transducing ion channel TRPV1 underlies thermal hyperalgesia by proalgesic agents such as nerve growth factor (NGF). The currently accepted model is that the NGF-mediated increase in TRPV1 function during hyperalgesia utilizes activation of phospholipase C (PLC) to cleave PIP2, proposed to tonically inhibit TRPV1. In this study, we tested the PLC model and found two lines of evidence that directly challenge its validity: (1) polylysine, a cationic phosphoinositide sequestering agent, inhibited TRPV1 instead of potentiating it, and (2) direct application of PIP2 to inside-out excised patches dramatically potentiated TRPV1. Furthermore, we show four types of experiments indicating that PI3K is physically and functionally coupled to TRPV1: (1) the p85beta subunit of PI3K interacted with the N-terminal region of TRPV1 in yeast 2-hybrid experiments, (2) PI3K-p85beta coimmunoprecipitated with TRPV1 from both HEK293 cells and dorsal root ganglia (DRG) neurons, (3) TRPV1 interacted with recombinant PI3K-p85 in vitro, and (4) wortmannin, a specific inhibitor of PI3K, completely abolished NGF-mediated sensitization in acutely dissociated DRG neurons. Finally, simultaneous electrophysiological and total internal reflection fluorescence (TIRF) microscopy recordings demonstrate that NGF increased the number of channels in the plasma membrane. We propose a new model for NGF-mediated hyperalgesia in which physical coupling of TRPV1 and PI3K in a signal transduction complex facilitates trafficking of TRPV1 to the plasma membrane.


Asunto(s)
Membrana Celular/metabolismo , Factor de Crecimiento Nervioso/fisiología , Fosfatidilinositol 3-Quinasas/metabolismo , Canales Catiónicos TRPV/metabolismo , Androstadienos/farmacología , Transporte Biológico/fisiología , Línea Celular , Electrofisiología , Humanos , Hiperalgesia/fisiopatología , Canales Iónicos/efectos de los fármacos , Canales Iónicos/fisiología , Fosfatidilinositol 4,5-Difosfato/farmacología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Polilisina/farmacología , Unión Proteica/fisiología , Inhibidores de Proteínas Quinasas/farmacología , Transducción de Señal/fisiología , Canales Catiónicos TRPV/antagonistas & inhibidores , Fosfolipasas de Tipo C/fisiología , Wortmanina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA